U.S. flag

An official website of the United States government

NM_173354.5(SIK1):c.2065T>A (p.Cys689Ser) AND Developmental and epileptic encephalopathy, 30

Germline classification:
Uncertain significance (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003446903.2

Allele description [Variation Report for NM_173354.5(SIK1):c.2065T>A (p.Cys689Ser)]

NM_173354.5(SIK1):c.2065T>A (p.Cys689Ser)

Gene:
SIK1:salt inducible kinase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
NM_173354.5(SIK1):c.2065T>A (p.Cys689Ser)
HGVS:
  • NC_000021.9:g.43417029A>T
  • NG_052009.1:g.15104T>A
  • NM_173354.5:c.2065T>AMANE SELECT
  • NP_775490.2:p.Cys689Ser
  • NC_000021.8:g.44836909A>T
  • NM_173354.3:c.2065T>A
Protein change:
C689S
Links:
dbSNP: rs772047499
NCBI 1000 Genomes Browser:
rs772047499
Molecular consequence:
  • NM_173354.5:c.2065T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 30 (DEE30)
Synonyms:
Epileptic encephalopathy, early infantile, 30
Identifiers:
MONDO: MONDO:0014595; MedGen: C4225360; OMIM: 616341

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004171927Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)		Uncertain significancegermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Neuberg Centre For Genomic Medicine, NCGM, SCV004171927.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The missense c.2065T>A(p.Cys689Ser) in SIK1 gene has not been reported previously as a pathogenic variant nor a benign variant, to our knowledge. The p.Cys689Ser variant is novel (not in any individuals) in both gnomAD Exomes and 1000 Genomes databases. This variant has been reported to the ClinVar database as Uncertain Significance. The amino acid change p.Cys689Ser in SIK1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Cys at position 689 is changed to a Ser changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as a Variant of Uncertain Significance (VUS).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 6, 2024